| Title |
Neuroinflammation and Non-motor Symptoms: The Dark Passenger of Parkinson’s Disease?
|
|---|---|
| Published in |
Current Neurology and Neuroscience Reports, May 2012
|
| DOI | 10.1007/s11910-012-0283-6 |
| Pubmed ID | |
| Authors |
Christopher J. Barnum, Malú G. Tansey |
| Abstract |
Generally speaking, inflammation as a key piece to the Parkinson's disease (PD) puzzle is a relatively new concept. Acceptance of this concept has gained ground as studies by various researchers have demonstrated the potential of mitigating nigral cell death by curtailing inflammation in animal models of PD. We propose that the significance of inflammation in PD pathology may extend beyond the nigrostriatal region. In the current review, we present an argument for this based on the Braak staging and discuss how inflammation might contribute to the development of non-motor PD symptoms. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Luxembourg | 2 | 2% |
| Germany | 1 | <1% |
| United Kingdom | 1 | <1% |
| Australia | 1 | <1% |
| United States | 1 | <1% |
| Spain | 1 | <1% |
| Unknown | 120 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 22 | 17% |
| Student > Ph. D. Student | 20 | 16% |
| Student > Master | 18 | 14% |
| Student > Bachelor | 15 | 12% |
| Other | 7 | 6% |
| Other | 22 | 17% |
| Unknown | 23 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 23 | 18% |
| Medicine and Dentistry | 21 | 17% |
| Neuroscience | 20 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 10% |
| Biochemistry, Genetics and Molecular Biology | 12 | 9% |
| Other | 13 | 10% |
| Unknown | 25 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2021.
All research outputs
#7,175,982
of 22,685,926 outputs
Outputs from Current Neurology and Neuroscience Reports
#380
of 913 outputs
Outputs of similar age
#52,031
of 163,807 outputs
Outputs of similar age from Current Neurology and Neuroscience Reports
#5
of 12 outputs
Altmetric has tracked 22,685,926 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 913 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.1. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,807 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 58% of its contemporaries.